Addex Therapeutics (ADXN) Equity Income (2024 - 2026)
Addex Therapeutics (ADXN) posted Equity Income of -$1.6 million for Q1 2026, down 19.16% sequentially from -$1.3 million in Q4 2025, and down 66.54% YoY from -$4.7 million in Q1 2025.
Addex Therapeutics (ADXN) Equity Income (2024 - 2026) Analysis & Trends
Addex Therapeutics has reported Equity Income for 3 years, with the latest figure at -$1.6 million in Q1 2026.
- Quarterly Equity Income fell 66.54% year-over-year to -$1.6 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$5.5 million (down 8.98% YoY) and the FY2025 annual result came in at -$4.8 million, down 93.52% from the prior year.
- Equity Income slipped to -$1.6 million in Q1 2026 per ADXN's latest filing, from -$1.3 million in the prior quarter.
- Over five years, Equity Income peaked at -$586898.8 in Q2 2024 and troughed at -$2.5 million in Q4 2024.
- A 3-year average of -$1.3 million and a median of -$1.2 million in 2025 frame the typical range for Equity Income.
- The widest YoY moves for Equity Income: up 46.99% in 2025, down 153.52% in 2025.
- Over 3 years, Equity Income stood at -$2.5 million in 2024, then jumped by 46.99% to -$1.3 million in 2025, then retreated by 19.16% to -$1.6 million in 2026.
- According to Business Quant data, Equity Income over the past three periods registered -$1.6 million, -$1.3 million, and -$1.1 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Equity Income (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | - |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | - |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | - |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | - |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 4.08 Mn |
| 10 | Addex Therapeutics | 534.71 Mn | 534.71 Mn | - | 1,569.76 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -1.57 Mn |
| Dec 31, 2025 | -1.32 Mn |
| Sep 30, 2025 | -1.10 Mn |
| Jun 30, 2025 | -1.49 Mn |
| Mar 31, 2025 | -942,577.83 |
| Dec 31, 2024 | -2.49 Mn |
| Sep 30, 2024 | -1.01 Mn |
| Jun 30, 2024 | -586,898.79 |